Navigation Links
Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program
Date:8/26/2010

therapy to enhance the benefit of both infectious disease and cancer treatment regimens. In this regard, we plan to commercialize our Hemopurifier® in India as we advance our clinical strategies in the United States and the European Union.  In vitro studies conducted by government and non-government research institutes have also verified that our Hemopurifier® has broad-spectrum capabilities against bioterror and emerging pandemic threats. These studies have confirmed the capture of Dengue Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1 Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus, and Monkeypox Virus, which serves as a model for human Smallpox infection.

As a therapeutic device, the Hemopurifier® provides us with a pipeline into four significant market opportunities:

  1. Cancer: A treatment candidate to improve patient responsiveness to established cancer therapies by removing immunosuppressive exosomes from circulation.
  2. Hepatitis-C Virus (HCV): As an adjunct therapy to accelerate viral load reduction at the outset of standard of care drug regimens.
  3. Human Immunodeficiency Virus (HIV):  Provides a potential therapeutic option for HIV-infected individuals to manage disease progression once they become resistant to antiviral drug regimens.
  4. Bioterror and Pandemic Threats:  Represents the most advanced broad-spectrum strategy to address untreatable bioterror and emerging pandemic threats.

The Hemopurifier® is an expansive multi-patented platform technology whose mechanism of action can be leveraged to provide therapeutic, diagnostic, and biomarker discovery solutions. As a therapeutic, the Hemopurifier® is a single-use disposable cartridge designed for implementation within the established infrastructure of dialysis machines and other blood circulatory
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Aethlon Medical to Present at the 2009 RedChip Small-Cap Investor Conference on June 16, 2009
2. Aethlon Medical Announces Presentation of Hepatitis-C (HCV) Clinical Data at 42nd Annual American Society of Nephrology (ASN) Conference
3. Aethlon Medical Releases Medical Device Data Against the H1N1 Swine Flu Virus
4. Aethlon Medical Discloses Live Webcast of Todays BIOCOM Presentation
5. Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. Globus Medical Raises $110 Million in Series E Financing Round
10. Quark Pharmaceuticals Appoints New Chief Medical Officer
11. Boston University Biomedical Engineers Find Chink in Bacterias Armor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 26, 2014  CARsgen, a leader in the ... to treat a variety of cancers, today announced the ... a China -based healthcare private equity ... focused on the development of new therapeutics for liver, ... Cancer Institute and Shanghai Renji Hospital, the company plans ...
(Date:11/26/2014)... Nov. 26, 2014 The medical magnetic ... rate of 4%, with world market revenues for ... MRI and other types of medical imaging have ... of numerous medical conditions in children and adults, ... Kalorama,s report, Medical Imaging Markets , analyzes ...
(Date:11/26/2014)... , November 25, 2014 ... Instruments Market by Power Source (Electric, Battery, Pneumatic), ... Cables, Blade, Burr, Cart), by Application (Orthopedic, ENT, ... published by MarketsandMarkets, the global Powered Surgical Instruments Market ... $1.6 Billion in 2014 and is expected to ...
Breaking Medicine Technology:CARsgen Completes Series A Financing 2Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4
... Holdings, LLC ("ClearChoice"), a market leading developer and manager ... same-day dental implant care, today announced a ... leading consumer-focused private equity firm. The investment ... accelerate its expansion plan to double the number of ...
... 6, 2011 Reportlinker.com announces that ... available in its catalogue: ... Emerging Opportunities ... of small-scale electronics and sophisticated biocompatible ...
Cached Medicine Technology:ClearChoice Receives Investment From Leading Consumer Private Equity Firm Catterton Partners 2ClearChoice Receives Investment From Leading Consumer Private Equity Firm Catterton Partners 3ClearChoice Receives Investment From Leading Consumer Private Equity Firm Catterton Partners 4Continuous Glucose Monitors: Evolving Technology, Emerging Opportunities 2Continuous Glucose Monitors: Evolving Technology, Emerging Opportunities 3
(Date:11/29/2014)... Syntermed, Inc. announces availability for its ... for the U.S. nuclear medicine market at the ... , “NeuroQ is well established and being ... of PET- FDG and Amyloid brain imaging studies, ... Michael Lee, CEO, Syntermed, Inc. “Radiologists and their departments ...
(Date:11/28/2014)... 2014 The emerging blend ... research in all the healthcare segments such ... support and population health management. The demand ... innovation in machine learning, logical methodologies, computational ... full report with full table of contents ...
(Date:11/28/2014)... November 29, 2014 The report ... information on the therapeutic development for Poxvirus Infections, ... assessment by drug target, mechanism of action (MoA), ... with latest updates, and featured news and press ... the therapeutic development for Poxvirus Infections and special ...
(Date:11/28/2014)... PrettyTailor.com has developed and created its new collection of ... in celebration of the coming holiday season. To show ... offer on all these outfits. Click here ... garment industry, PrettyTailor.com brings together art and technology to ... business carries quite a few in eye-catching patterns for ...
(Date:11/28/2014)... 29, 2014 The holiday season is fast ... announced its new collection of fashionable party dresses. What’s more, ... on all these brand new outfits; the special offer is ... a renowned online supplier and it has received a lot ... items are specially designed to flatter various body shapes; they ...
Breaking Medicine News(10 mins):Health News:Syntermed's NeuroQ™ 3.7 for SPECT Brain Imaging Announced at RSNA 2Health News:Syntermed's NeuroQ™ 3.7 for SPECT Brain Imaging Announced at RSNA 3Health News:Medical & Healthcare Analytics Market Report: Global Industry Size, Share, Trends, Growth and Forecast by Researchmoz.us 2Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 2Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 3Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 4Health News:2015 Wedding Dresses from PrettyTailor.com Available Now 2Health News:Trendy Party Dresses For The Coming Holiday Season From Balfleet.com 2
... ... Thomas A. Einhorn Advances Safe and Successful Adult Stem Cell Therapy To Eliminate Hip ... ... A. Einhorn , internationally renowned Orthopaedic Surgeon and Chairman of the Department of Orthopaedic ...
... Members ... , ... 2010 -- With summer just around the corner, many people are hoping to tone up in ... Predicto Mobile community to ponder some weighty issues this spring. Members of Snackable ...
... a world first study of its kind, 161 postnatal ... two separate groups to test the effect of a ... The experimental group received an eight-week "Mother and Baby" ... physiotherapist combined with parenting education. In the ...
... loss, metastasis, study finds , WEDNESDAY, March 31 ... (Zometa) reduces the spread of breast cancer by ... , Tumor cells released from the primary breast ... and spread from there to other areas of ...
... slash youngsters, consumption, study finds , THURSDAY, April 1 (HealthDay ... soda consumption, a new study finds. , Although taxes ... efforts to fight childhood obesity, they may have to be ... is to noticeably reduce soda consumption among children, then it ...
... for Art & Healing today releases the proceedings from its ... luminaries from the medical, arts and public health sectors regarding ... during the summer of 2009 in New York, the goal ... expertise as well as the direct experiences of cardiac patients ...
Cached Medicine News:Health News:Leading Orthopaedic Surgeon and Regenerative Medical Authority Dr. Thomas A. Einhorn Advances Adult Stem Cell Therapy To Eliminate Hip Replacement Surgery 2Health News:Leading Orthopaedic Surgeon and Regenerative Medical Authority Dr. Thomas A. Einhorn Advances Adult Stem Cell Therapy To Eliminate Hip Replacement Surgery 3Health News:Leading Orthopaedic Surgeon and Regenerative Medical Authority Dr. Thomas A. Einhorn Advances Adult Stem Cell Therapy To Eliminate Hip Replacement Surgery 4Health News:Predicto Mobile Community Weighs in on Celebrity Weight Loss 2Health News:Predicto Mobile Community Weighs in on Celebrity Weight Loss 3Health News:New mums beat the blues and increase wellbeing with physio exercise, study reveals 2Health News:Bone-Strengthening Drug Guards Against Spread of Breast Cancer 2Health News:Small Tax on Soda Won't Curb Child Obesity 2Health News:The creative engagement and cardiac health connection disclosed 2Health News:The creative engagement and cardiac health connection disclosed 3
The ThermaViewer™ is constructed and engineered for use in laboratories, hospitals, and commercial kitchens to monitor and document freezer and refrigerator temperatures where inventory is store...
... as three tests confirmed Sterillium Rub's extremely ... to FDA (Time Kill study and Tentative ... Products) and one European test - with ... relevant international efficacy specifications. Sterillium Rub with ...
... This requiring no water for ... hand hygiene to physically clean ... is either not an option ... allows you to return to ...
HIBICLENS' non-drying, low skin irritation potential promotes compliance with the frequent hand washing associated with today's clinical protocols....
Medicine Products: